Manage­ment

Management

Michael Scholl

CEO

Michael Scholl

Less information More information

Michael is CEO and Co-Founder of Leukocare, heading strategy, finance, corporate law, marketing & sales and HR. Before joining Leukocare, Michael was an entrepreneur and investor and founded several technology companies. He started his career as business consultant at BCG. Michael holds a master’s degree in business engineering from the University of Berlin.

Dr. Andreas Seidl

COO

Dr. Andreas Seidl

Less information More information

Andreas is COO of Leukocare, heading R&D, IP, quality management and Bioinformatics. Andreas has about 20 years experience in analytical and pharmaceutical development of biologics and contributed to the development and approval of many biosimilar products and NBEs. Before joining Leukocare, Andreas held different positions with growing responsibility at Hexal AG, Sandoz Biopharmaceuticals and Novartis. Andreas is a chemist by training with a master’s degree from the University of Constance/Germany and received his Ph.D. in the area of protein analysis and mass spectrometry from the University of Constance.

Dr. Konstantin Petropoulos

Dr. Konstantin Petropoulos

VP, Head of BD, Marketing & Sales

Less information More information

Konstantin has more than 10 years of experience in the biotech & pharma industry. Prior to joining Leukocare, Konstantin held different positions with increasing responsibility at Bayer AG & MorphoSys AG. He holds a PhD in Molecular Biology from Ludwig-Maximilians-University Munich and an MBA from FOM University of Applied Sciences.

Dr. Sabine Hauck

Dr. Sabine Hauck

VP, Head of R&D

Less information More information

Sabine brings 20 years of Drug Product development expertise as well as several years of in vitro diagnostic and biosensor development to Leukocare. Before joining Leukocare, Sabine was heading Pharmaceutical Development, QA and RA departments (Medigene, Acino, IDEA). She holds a Dr. rer. nat. from University of Regensburg.

Dr. Georg Dönges

Dr. Georg Dönges

VP, Head of Finance

Less information More information

Georg has spent more than 10 years in leading positions in the biotech industry & capital markets. He held various positions in a large finance org., eg. lead for restructuring of Corp. Finance at GfK SE, a KKR portfolio company. Previously, Georg worked at the Max-Planck-Institute of Biochemistry for his PhD thesis and earned the degree of a Certified International Investment Analyst (CIIA).

Dr. Andreas Geissler

Dr. Andreas Geissler

VP, Head of IP

Less information More information

Andreas has been counseling pharmaceutical biotech companies on IP strategy for more than 15 years. He is a European and German Patent Attorney. Before joining Leukocare, Andreas served as Head of IP (Medigene) and attorney in private practice. He has in depth experience in IP strategy, portfolio management, patent prosecution, and FTO analysis. He holds a PhD in Molecular Cell Biology from Albert-Ludwigs-University Freiburg.